This Is HCM Real Talk
Hypertrophic cardiomyopathy (HCM)
is a serious heart condition affecting anywhere from 1 in 500 people,* to as many as
*The 1995 CARDIA study, a multicenter, US-population-based echocardiography study of 4111 subjects (aged 23-35), identified the prevalence of HCM as 1:500 people in the general population.
†The 2015 Semsarian publication identified that the prevalence of HCM gene carriers could be as high as 1:200.
Common symptoms of HCM include shortness of breath, tiredness, rapid heartbeat, chest pain, feeling dizzy or light-headed, fainting, and fatigue.
Understanding Treatment Options
Medication that treats symptoms
Beta blockers, calcium channel blockers,
and/or disopyramide.
Commonly used to help treat the
symptoms of HCM but most are not FDA
approved for this use.
Surgery that treats obstruction
Septal reduction therapy includes alcohol septal ablation and septal myectomy.
Used for severe obstruction or when HCM continues to worsen even
with medication.
Medication that treats symptoms and obstruction
A treatment option that works inside the heart muscle to treat HCM.
FDA approved to treat symptomatic obstructive HCM.
Talking to Your Cardiologist
Nicole was still short of breath on a beta
blocker so she did her research and asked
her cardiologist about advances in HCM.
If you have been diagnosed with obstructive HCM and still have
symptoms on your current treatment, talk to your cardiologist.
Find out what treatment advances may be out there for you.
